Total and high-molecular-weight adiponectin and risk of incident diabetes in older people

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 415-423

  Kizer, Jorge R ^a   Barzilay, Joshua I ^f   Arnold, Alice M ^b   Tracy, Russell P ^g   Benkeser, David ^b   Mantzoros, Christos S ^h,i   Ix, Joachim H ^c   Siscovick, David S ^j   Djousse, Luc ^d   Mukamal, Kenneth J ^h   Zieman, Susan J ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF VERMONT   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; LIPID;

AGED; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; UNITED STATES;

ADIPONECTIN; AGED; DIABETES MELLITUS; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 84859062772     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1519     Document Type: Article

References (29)

1. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294
2. Sloan FA, Bethel MA, Ruiz D Jr, Shea AM, Feinglos MN. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med 2008;168:192-199; discussion 199
3. Meneilly GS. Diabetes inthe elderly. Med Clin North Am 2006;90:909-923
4. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 2007;21: 1443-1455 (Pubitemid 46955717)
5. Ziemke F, Mantzoros CS. Adiponectin ininsulin resistance: lessons from translational research. Am J Clin Nutr 2010;91:258S-261S
6. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-1792 (Pubitemid 44033298)
7. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004;279:12152-12162 (Pubitemid 38445780)
8. Lee YH, Magkos F, Mantzoros CS, Kang ES. Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism 2011;60:1664-1672
9. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and metaanalysis. JAMA 2009;302:179-188
10. Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007;30:1200-1205 (Pubitemid 46684648)
11. Kanaya AM, Wassel Fyr C, Vittinghoff E, et al. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. Arch Intern Med 2006;166:350-356 (Pubitemid 43244324)
12. Heidemann C, Sun Q, van Dam RM, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008;149:307-316
13. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006;91:3873-3877 (Pubitemid 44536857)
14. Zhu N, Pankow JS, Ballantyne CM, et al. High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J Clin Endocrinol Metab 2010;95: 5097-5104
15. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1: 263-276
16. Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 1995;5:270-277
17. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 1995;41: 264-270
18. Teng EL, Chui HC. The Modified Mini- Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318 (Pubitemid 17138128)
19. Biggs ML, Mukamal KJ, Luchsinger JA, et al. Association between adiposity inmidlife and older age and risk of diabetes in older adults. JAMA 2010;303:2504-2512
20. Newman AB, Arnold AM, Sachs MC, et al. Long-termfunction inan older cohortdthe Cardiovascular Health Study All Stars Study. J Am Geriatr Soc 2009;57:432-440
21. Macy EM, Hayes TE, Tracy RP. Variability inthe measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-58 (Pubitemid 27024390)
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419 (Pubitemid 15018832)
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
24. Hastie TJ, Hibishani R. Generalized additive models. Boca Raton, Florida, Chapman & Hall/CRC, 1990
25. Kizer JR, Arnold AM, Jenny NS, et al. Longitudinal changes inadiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci 2011;66A:1100-1107
26. Sattar N, Nelson SM. Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. J Clin Endocrinol Metab 2008;93:3299-3301
27. Snijder MB, Heine RJ, Seidell JC, et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn Study. Diabetes Care 2006;29: 2498-2503 (Pubitemid 44912259)
28. Hivert MF, Sullivan LM, Shrader P, et al. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia 2011;54: 1019-1024
29. Kizer JR, Biggs ML, Ix JH, et al. Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol 2011; 173:10-25